| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |